[HTML][HTML] Consistent terminology for medication-related problems in pharmacogenomic cases

TM Polasek, S Mostafa, CMJ Kirkpatrick - Journal of Psychiatry and …, 2023 - jpn.ca
We read with interest the case report by Korchia and colleagues in which pharmacogenomic
testing was used to investigate a young man's adverse effects to 3 different antipsychotics. 1 …

[PDF][PDF] Should you order genetic testing to identify how patients metabolize antipsychotics?

VL Ellingrod - Current Psychiatry, 2010 - cdn.mdedge.com
Savvy Psychopharmacology done, 8 and iloperidone9 (Figure, page 34). On the other end
of the spectrum are UMs. Because of gene duplication, patients who fall into this category …

The participation of cytochrome P450 3A4 in clozapine biotransformation is detected in people with schizophrenia by high-throughput in vivo phenotyping

S Ghassabian, M Chetty, BN Tattam… - Journal of clinical …, 2010 - journals.lww.com
DISCUSSION This patient's clinical history and physical examination strongly support the
diagnosis of serotonin toxicity as outlined by Dunkley et al. 6 The presentation is unlikely to …

[HTML][HTML] Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype

E Marcos-Vadillo, L Carrascal-Laso… - Frontiers in …, 2022 - frontiersin.org
Precision medicine applied to psychiatry provides new insight into the promising field of
precision psychiatry. Psychotic disorders are heterogeneous, complex, chronic, and severe …

[HTML][HTML] Mindful pharmacogenetics: drug dosing for mental health

JC Stingl - American Journal of Psychiatry, 2018 - Am Psychiatric Assoc
Pharmacogenetics may be said to have paved the way to personalized medicine. Genotype-
adjusted dosing recommendations for psychopharmacological treatment are decades old …

Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers

J de Leon, L Dinsmore, P Wedlund - Journal of clinical …, 2003 - journals.lww.com
DISCUSSION These cases suggest potential benefits of olanzapine in substance use
disorders. Previous reports suggested that olanzapine decreased substance use in …

[HTML][HTML] Misleading guidance from pharmacogenomic testing

T Rahman, DM Ash, J Lauriello… - American Journal of …, 2017 - Am Psychiatric Assoc
In order to better understand the management of cases such as Mr. A's involving
pharmacogenetic testing issues in psychiatry, it is important to have some understanding of …

[HTML][HTML] The three ps: Psychiatry, pharmacy, and pharmacogenomics, a brief report from New Zealand

SDS Maggo, KLV Sycamore, AL Miller… - Frontiers in …, 2019 - frontiersin.org
We describe a case series of 22 individuals who were referred to our laboratory by a
pharmacist based in a mental health hospital, for pharmacogenetic analysis due to severe or …

Highlights of drug package inserts and the website DailyMed: the need for further improvement in package inserts to help busy prescribers

J de Leon - Journal of clinical psychopharmacology, 2011 - journals.lww.com
Administration (FDA) enacted some useful reforms in 20061; more are needed. Until a
number of drugs were withdrawn from the US market after previously receiving approval, 2 …

[HTML][HTML] Case report: Avoiding intolerance to antipsychotics through a personalized treatment approach based on pharmacogenetics

L Korošec Hudnik, T Blagus… - Frontiers in …, 2024 - frontiersin.org
Introduction The standard approach to treatment in psychiatry is known as “treatment as
usual”(TAU), in which the same types of treatment are administered to a group of patients …